Recce Pharmaceuticals completes cohort dosing in R327 Phase I/II trial

Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) continues its trajectory in pioneering a new class of Synthetic Antiinfectives, spotlighting its recent achievement. The company announced that Scientia ... Read More